Pegasus Biotech

Pegasus Biotech provides contract research services focused on the development of vaccines—including DNA, recombinant protein, autogenous, and VLP-based—for both human and animal health. They have developed a proprietary low-cost DNA plasmid platform to enable more affordable vaccine production. The company supports clients from proof-of-concept through process validation, regulatory submission, and technology transfer. Most work involves analytical method development, process optimization, regulatory consulting (EMA/CFIA/FDA/USDA), with a strong focus on commercialization-readiness. No direct clinical trial results or proprietary therapeutic programs are publicly disclosed.